PreDxion Bio YC 申请

Summer 2017Inactive

PreDxion Bio 在 Summer 2017 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。

YC 批次: Summer 2017
行业: HealthcareDiagnostics
团队规模: 6
状态: Inactive
已发布: 2017

创始人

Walker McHughFounder
Timothy CornellFounder

PreDxion Bio 做什么

PreDxion Bio is working on a rapid saliva-based antigen test for the detection of SARS-CoV-2 S-protein in asymptomatic and presymptomatic patients. Our technology is uniquely capable of being scaled to 10's of millions of tests of days using semiconductor fab processes, a scale of testing necessary to better inform public health officials and policymakers and enable contact tracing at scale. PreDxion Bio's origins are in critical care: our original technology is a rapid, near real-time cytokine and biomarker detection platform to monitor the immune response of critically-ill patients. This technology leverages a novel sensor platform we spun out of the University of Michigan. PreDxion Bio has received FDA Breakthrough Device designation and partnered with top pharmcos to monitor the immune response following CAR-T therapy and predict the development of cytokine release syndrome and neurological AEs, and for use in guiding precision medicine approaches in critical care.

PreDxion Bio 的 YC 申请，重建版

Y Combinator 申请

PreDxion Bio，Summer 2017 期。来自公开数据的真实申请问题解答。

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

PreDxion Bio

Describe what your company does in 50 characters or less.

Rapid, scalable diagnostic for SARS-CoV-2 and beyond

What is your company going to make? Please describe your product and what it does or will do.

We build a rapid antigen test that detects the SARS-CoV-2 spike protein from saliva, targeting asymptomatic and presymptomatic carriers. Our platform uses semiconductor fab processes allowing us to scale to tens of millions of tests in days. We originally started with sensors that monitor immune responses in critical care, now pivoting to large-scale infectious disease diagnostics.

Where do you live now, and where would the company be based after YC?

We are based in South San Francisco now and plan to remain here after YC, to stay close to biotech and semiconductor partners.

Explain your decision regarding location.

South San Francisco situates us amid biotech and diagnostics companies, and semiconductor fabs nearby for scaling manufacturing. It's critical for integrating our microfluidics and nanosensor technology with existing infrastructure.

21 更多回答在完整申请中

Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。

查看完整申请

常见问题解答

这是 PreDxion Bio 的真实 YC 申请吗？

不是。Y Combinator 对提交的申请保密。这是重建版：使用 PreDxion Bio 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 PreDxion Bio 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。

PreDxion Bio 是哪个 YC 批次的？

PreDxion Bio 是 Y Combinator Summer 2017 批次的成员。

谁创立了 PreDxion Bio？

PreDxion Bio 由 Walker McHugh, Timothy Cornell 创立。

PreDxion Bio 做什么？